{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:57:39Z","timestamp":1793933859125,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-03984-w","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T15:09:51Z","timestamp":1738854591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association between triglyceride-glucose index and clinical outcomes among patients with chronic kidney disease: a meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jinli","family":"Tuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linshen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"10075","key":"3984_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389(10075):1238\u201352.","journal-title":"Lancet"},{"issue":"9888","key":"3984_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372.","journal-title":"Lancet"},{"key":"3984_CR3","doi-asserted-by":"crossref","unstructured":"KDIGO. 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2022, 102(5s):S1-s127.","DOI":"10.1016\/j.kint.2022.06.008"},{"issue":"2","key":"3984_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, et al. Effects of Semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391(2):109\u201321.","journal-title":"N Engl J Med"},{"issue":"9","key":"3984_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMc1602469","volume":"375","author":"L Zhang","year":"2016","unstructured":"Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z, Li Y, Yeung RO, Wang J, Matsushita K, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375(9):905\u20136.","journal-title":"N Engl J Med"},{"issue":"9","key":"3984_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrendo.2013.102","volume":"9","author":"AP Kong","year":"2013","unstructured":"Kong AP, Xu G, Brown N, So WY, Ma RC, Chan JC. Diabetes and its comorbidities\u2013where East meets West. Nat Rev Endocrinol. 2013;9(9):537\u201347.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"3984_CR7","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"3984_CR8","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1002\/cphy.c220019","volume":"13","author":"VP Parvathareddy","year":"2023","unstructured":"Parvathareddy VP, Wu J, Thomas SS. Insulin Resistance and insulin handling in chronic kidney disease. Compr Physiol. 2023;13(4):5069\u201376.","journal-title":"Compr Physiol"},{"key":"3984_CR9","doi-asserted-by":"publisher","first-page":"644035","DOI":"10.3389\/fcvm.2021.644035","volume":"8","author":"Y Wang","year":"2021","unstructured":"Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a Meta-analysis. Front Cardiovasc Med. 2021;8:644035.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3984_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, Ma J, Zhao Y, Zhu W, Wang J. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3984_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12933-022-01732-0","volume":"22","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang X, Wang Y, Leng L, Xu J, Feng L, Jiang S, Wang J, Yang Y, Pan G, et al. The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):2.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3984_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.numecd.2023.03.026","volume":"33","author":"X Ren","year":"2023","unstructured":"Ren X, Jiang M, Han L, Zheng X. Association between triglyceride-glucose index and chronic kidney disease: a cohort study and meta-analysis. Nutr Metab Cardiovasc Dis. 2023;33(6):1121\u20138.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3984_CR13","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Res ed). 2021;372:n71.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"11","key":"3984_CR14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.jtho.2021.07.001","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li J, Chang S, Dong Y, Che G. Risk and influencing factors for subsequent primary Lung Cancer after treatment of breast Cancer: a systematic review and two Meta-analyses based on four million cases. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2021;16(11):1893\u2013908.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"1","key":"3984_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12882-020-01718-8","volume":"21","author":"AR Choe","year":"2020","unstructured":"Choe AR, Ryu DR, Kim HY, Lee HA, Lim J, Kim JS, Lee JK, Kim TH, Yoo K. Noninvasive indices for predicting nonalcoholic fatty liver disease in patients with chronic kidney disease. BMC Nephrol. 2020;21(1):50.","journal-title":"BMC Nephrol"},{"issue":"10","key":"3984_CR16","first-page":"1023","volume":"43","author":"Q Chen","year":"2022","unstructured":"Chen Q, Liang W, Zhao Q, Cao L. The predictive value of TyG index for new cardiovascular events in patients with chronic kidney disease. Sichuan Med J. 2022;43(10):1023\u20138.","journal-title":"Sichuan Med J"},{"issue":"9","key":"3984_CR17","first-page":"827","volume":"38","author":"X Guan","year":"2022","unstructured":"Guan X, Lin L, Yang Y, Hu X, Liu B, Liu H. Relationship between triglyceride-glucose index and coronary artery heart disease and coronary artery stenosis severity in patients with chronic kidney disease. Chin J Nephrol. 2022;38(9):827\u20139.","journal-title":"Chin J Nephrol"},{"issue":"4","key":"3984_CR18","doi-asserted-by":"publisher","first-page":"147916412211137","DOI":"10.1177\/14791641221113784","volume":"19","author":"S Low","year":"2022","unstructured":"Low S, Pek S, Moh A, Ang K, Khoo J, Shao YM, Tang WE, Lim Z, Subramaniam T, Sum CF, et al. Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in type 2 diabetes - mediation by pigment epithelium-derived factor. Diab Vasc Dis Res. 2022;19(4):14791641221113784.","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"3984_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12020-023-03357-z","volume":"81","author":"S Duan","year":"2023","unstructured":"Duan S, Zhou M, Lu F, Chen C, Chen S, Geng L, Zhang C, Guo H, Zeng M, Sun B, et al. Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes. Endocrine. 2023;81(1):77\u201389.","journal-title":"Endocrine"},{"key":"3984_CR20","doi-asserted-by":"publisher","first-page":"1150980","DOI":"10.3389\/fendo.2023.1150980","volume":"14","author":"YM Gao","year":"2023","unstructured":"Gao YM, Chen WJ, Deng ZL, Shang Z, Wang Y. Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease. Front Endocrinol (Lausanne). 2023;14:1150980.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3984_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-023-01843-2","volume":"22","author":"Z Ye","year":"2023","unstructured":"Ye Z, An S, Gao Y, Xie E, Zhao X, Guo Z, Li Y, Shen N, Zheng J. Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovasc Diabetol. 2023;22(1):110.","journal-title":"Cardiovasc Diabetol"},{"key":"3984_CR22","doi-asserted-by":"crossref","unstructured":"Chen Y, Li S, Yang K, Wu B, Xie D, Peng C, Lai W. Triglyceride-glucose index and prognosis in individuals afflicted with heart failure and chronic kidney disease. ESC Heart Fail 2024.","DOI":"10.1002\/ehf2.14898"},{"issue":"3","key":"3984_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.23876\/j.krcp.23.264","volume":"43","author":"YE Ko","year":"2024","unstructured":"Ko YE, Kim HW, Park JT, Han SH, Kang SW, Sung S, Lee KB, Lee J, Oh KH, Yoo TH. Triglyceride-glucose index is an independent predictor of coronary artery calcification progression in patients with chronic kidney disease. Kidney Res Clin Pract. 2024;43(3):381\u201390.","journal-title":"Kidney Res Clin Pract"},{"issue":"8","key":"3984_CR24","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s11255-024-04005-9","volume":"56","author":"K Li","year":"2024","unstructured":"Li K, Hou Q, Li X, Tian L, Wang L, Wu S, Han Q. Triglyceride-glucose index predicts major adverse cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2024;56(8):2793\u2013802.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3984_CR25","doi-asserted-by":"publisher","first-page":"2320261","DOI":"10.1080\/0886022X.2024.2320261","volume":"46","author":"D Liu","year":"2024","unstructured":"Liu D, Guan X, Chen R, Song C, Qiu S, Xu S, Cao J, Liu H. The clinical evaluation of the triglyceride-glucose index as a risk factor for coronary artery disease and severity of coronary artery stenosis in patients with chronic kidney disease. Ren Fail. 2024;46(1):2320261.","journal-title":"Ren Fail"},{"issue":"8","key":"3984_CR26","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.numecd.2024.04.003","volume":"34","author":"Y Qin","year":"2024","unstructured":"Qin Y, Xuan L, Deng Y, Wang F, Liu B, Wang S. Triglyceride-glucose index and mortality risk in individuals with or without chronic kidney disease: insights from a national survey of United States adults, 1999\u20132018. Nutr Metab Cardiovasc Dis. 2024;34(8):1994\u20132001.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3984_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12882-015-0068-7","volume":"16","author":"BT Lee","year":"2015","unstructured":"Lee BT, Ahmed FA, Hamm LL, Teran FJ, Chen CS, Liu Y, Shah K, Rifai N, Batuman V, Simon EE, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77.","journal-title":"BMC Nephrol"},{"issue":"6","key":"3984_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","volume":"34","author":"K Daenen","year":"2019","unstructured":"Daenen K, Andries A, Mekahli D, Van Schepdael A, Jouret F, Bammens B. Oxidative stress in chronic kidney disease. Pediatr Nephrol. 2019;34(6):975\u201391.","journal-title":"Pediatr Nephrol"},{"issue":"22","key":"3984_CR29","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","volume":"387","author":"S Bhandari","year":"2022","unstructured":"Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, Chadburn M, Cockwell P. Renin-angiotensin system inhibition in Advanced chronic kidney disease. N Engl J Med. 2022;387(22):2021\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"3984_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3892\/etm.2023.11852","volume":"25","author":"MA Maranduca","year":"2023","unstructured":"Maranduca MA, Clim A, Pinzariu AC, Statescu C, Sascau RA, Tanase DM, Serban DN, Branisteanu DC, Branisteanu DE, Huzum B, et al. Role of arterial hypertension and angiotensin II in chronic kidney disease (review). Exp Ther Med. 2023;25(4):153.","journal-title":"Exp Ther Med"},{"key":"3984_CR31","doi-asserted-by":"crossref","unstructured":"Tsai HJ, Hung CH, Wang CW, Tu HP, Li CH, Tsai CC, Lin WY, Chen SC, Kuo CH. Associations among Heavy metals and Proteinuria and chronic kidney disease. Diagnostics (Basel) 2021, 11(2).","DOI":"10.3390\/diagnostics11020282"},{"issue":"2","key":"3984_CR32","first-page":"162","volume":"45","author":"JCC Nunes Filho","year":"2023","unstructured":"Nunes Filho JCC, Camur\u00e7a DS, Rocha GA, Oliveira ABT, Marinho GCP, Santos SGM, Pereira D, Meneses GC, Daher EF. Chronic kidney disease prevention campaign: relationship between proteinuria and elderly people. J Bras Nefrol. 2023;45(2):162\u20138.","journal-title":"J Bras Nefrol"},{"issue":"2","key":"3984_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1053\/j.jrn.2014.10.019","volume":"25","author":"D Teta","year":"2015","unstructured":"Teta D. Insulin resistance as a therapeutic target for chronic kidney disease. J Ren Nutr. 2015;25(2):226\u20139.","journal-title":"J Ren Nutr"},{"issue":"6","key":"3984_CR34","doi-asserted-by":"publisher","first-page":"693","DOI":"10.7326\/M23-1874","volume":"177","author":"FS Yen","year":"2024","unstructured":"Yen FS, Hwu CM, Liu JS, Wu YL, Chong K, Hsu CC. Sodium-glucose Cotransporter-2 inhibitors and the risk for Dialysis and Cardiovascular Disease in patients with stage 5 chronic kidney disease. Ann Intern Med. 2024;177(6):693\u2013700.","journal-title":"Ann Intern Med"},{"issue":"3","key":"3984_CR35","doi-asserted-by":"publisher","first-page":"e221169","DOI":"10.1001\/jamanetworkopen.2022.1169","volume":"5","author":"JJ Chen","year":"2022","unstructured":"Chen JJ, Wu CY, Jenq CC, Lee TH, Tsai CY, Tu HT, Huang YT, Yen CL, Yen TH, Chen YC, et al. Association of Glucagon-Like Peptide-1 receptor agonist vs Dipeptidyl Peptidase-4 inhibitor Use with Mortality among patients with type 2 diabetes and advanced chronic kidney disease. JAMA Netw Open. 2022;5(3):e221169.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"3984_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.ekir.2023.08.021","volume":"8","author":"M Colladant","year":"2023","unstructured":"Colladant M, Chabannes M, Crepin T, Bamoulid J, Courivaud C, Ducloux D. Triglyceride-glucose Index and Cardiovascular events in kidney transplant recipients. Kidney Int Rep. 2023;8(11):2307\u201314.","journal-title":"Kidney Int Rep"},{"key":"3984_CR37","doi-asserted-by":"publisher","first-page":"691369","DOI":"10.1155\/2012\/691369","volume":"2012","author":"MT Liao","year":"2012","unstructured":"Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC. Insulin resistance in patients with chronic kidney disease. J Biomed Biotechnol. 2012;2012:691369.","journal-title":"J Biomed Biotechnol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-03984-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-03984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T15:09:55Z","timestamp":1738854595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-03984-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-03984-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in studies that involved human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}